<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900514-0029</DOCNO><DOCID>900514-0029.</DOCID><HL>   Business Brief -- Genetics Institute Inc.:   Joint Venture to Develop   Drugs to Aid Bone Growth</HL><DATE>05/14/90</DATE><SO>WALL STREET JOURNAL (J), PAGE A5E</SO><CO>   GENI</CO><LP>   Genetics Institute Inc. said it expects to announce on May21 the formation of a joint venture between it and a Japanesecompany to develop drugs that promote bone growth.   The company said the venture will focus on bonemorphogenetic proteins, which may someday help in treatingorthopedic, dental and other bone disorders.</LP><TEXT>   Last year, the biotechnology concern reported that it wasawarded a U.S. patent for bone morphogenetic protein-1, orBMP-1, a substance that can induce formation of newcartilage. The company also has filed patent applications onother BMP proteins.   Genetics Institute, Cambridge, Mass., said terms of theJapanese joint venture will allow it to retain North Americanrights to the potential BMP products.</TEXT></DOC>